With Provagin®, Biolab innovates in women's intimate health care
In women's busy routines, practicality and well-being are indispensable for dealing with the challenges of everyday life with ease. With this in mind, Biolab Farmacêutica has developed Provagin®, an intravaginal moisturizing gel that relieves dryness, discomfort and pain during sexual intercourse, as well as helping to reduce itching and irritation in the intimate area. With moisturizing power that can last up to three days, the product promotes prolonged comfort and continuous care.
The main active ingredient in Provagin® is sodium hyaluronate, a substance recognized for its ability to promote and maintain the natural moisture of the vaginal mucosa. It is effective in relieving symptoms associated with various conditions, such as the climacteric, postpartum, vaginismus, side effects of hormonal contraceptives, post-treatment periods of urogynecological surgery or hormonal changes.
Designed especially for women's well-being and safety, Provagin® is free from parabens, hormones and petroleum derivatives, guaranteeing a smooth and effective application.
The Provagin® package includes 10 applicators, which offer practicality of use and ensure up to 30 days of care, resulting in the lowest cost per applicator on the market. With Provagin®, Biolab reaffirms its commitment to innovation and women's intimate health, offering a safe, affordable solution for women's daily well-being.
About Biolab
Promoting a future with a better quality of life requires a tireless search for safe and innovative treatments. That's why Biolab, a Brazilian pharmaceutical company founded in 1997 and with an international presence, invests in research and partnerships to overcome the growing challenges of health.
With almost 4,000 employees and the 4th largest sales force in the country, the company stands out among Brazil's largest pharmaceutical companies. In 2025, it was recognized by LinkedIn Top Companies as one of the 15 best places to work in Brazil, based on criteria such as growth opportunities, skills development, diversity and stability.
Biolab operates in various specialties, such as dermatology, gynecology, orthopedics, gastroenterology, pediatrics, clinical medicine and the central nervous system, as well as being a leader in cardiology. The Biolab Genéricos, Avert Humana and Avert Biolab Saúde Animal business units contribute to a portfolio of more than 500 products.